IDentaIDTA 44 EV-to-FCF is 20.47 as of Jul. 06, 2026, which is 344% above its 10-year median of 4.61. GuruFocus rates IDTA with a GF Score™ of 44/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, IDenta ranks better than 58.16% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, IDenta's Enterprise Value is $1.43 Mil.
IDenta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0.07 Mil. Therefore, IDenta's EV-to-FCF for today is 20.47.
The historical rank and industry rank for IDenta's EV-to-FCF or its related term are showing as below:
IDTA'
s EV-to-FCF Range Over the Past 10 Years
Min: -105.58 Med: 4.61 Max: 428.31
Current: 20.47
During the past 8 years, the highest EV-to-FCF of IDenta was 428.31. The lowest was -105.58. And the median was 4.61.
IDTA's EV-to-FCF is ranked better than 58.16% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.975
vs IDTA: 20.47
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-06), IDenta's stock price is $0.275.
IDenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.041. Therefore, IDenta's PE Ratio (TTM) for today is 6.71.
IDenta (OTCPK:IDTA) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
IDenta's share price for today is $0.275.
IDenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.041.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
IDenta EV-to-FCF Related Terms
IDenta EV-to-FCF Historical Data
* Premium members only.
The historical data trend for IDenta's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, IDenta's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDenta EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDenta's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where IDenta's EV-to-FCF falls into.
IDenta's current Enterprise Value is $1.43 Mil.
IDenta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDenta (IDTA) has a EV-to-FCF of 20.47 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IDenta and its competitors. This is 344% above median its historical median of 4.61. According to the industry distribution chart, IDenta ranks #41 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 41.8%.
Is IDenta's EV-to-FCF too high?
IDenta's current EV-to-FCF of 20.47 is 344% above median its 10-year median of 4.61. The Medical Diagnostics & Research industry median EV-to-FCF is 22.98. IDenta's value of 20.47 is 10.9% below this industry median. Based on the distribution chart, IDenta ranks #41 out of 98 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, IDenta has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDenta's EV-to-FCF compare to NSTM and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, IDenta ranks #41 out of 98 companies for EV-to-FCF. This puts IDenta in the upper half of its industry. The industry median EV-to-FCF is 22.98. IDenta's value of 20.47 is 10.9% below this benchmark. While the company's 10-year median is 4.61 vs. the industry median of 22.98, IDenta has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.98, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDenta's current EV-to-FCF of 20.47 is 10.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on IDenta and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDenta's current EV-to-FCF is 20.47, which is 344% above median its own 10-year median of 4.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDenta stock overvalued right now?
Based on GuruFocus' analysis, IDenta (IDTA) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.28 — trading 21.4% below its estimated fair value. The current EV-to-FCF is 20.47, which is 344% above median its 10-year median of 4.61 and 10.9% below the Medical Diagnostics & Research industry median of 22.98. IDenta's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For IDenta (IDTA), the current EV-to-FCF is 20.47 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDenta (IDTA) Overvalued in 2026?
Based on GuruFocus' analysis, IDenta stock appears to be undervalued.
The current stock price of $0.28 is trading 21.4% below its estimated GF Value™ of $0.35.
GuruFocus considers IDenta to be Modestly Undervalued.
Key valuation signals for IDTA:
EV-to-FCF: 20.47 (344% above median its 10-year median of 4.61)
GF Value™: $0.35 vs. price of $0.28 (21.4% below fair value)
Industry Position: 10.9% below the Medical Diagnostics & Research median (#41 of 98)
No single metric tells the full story. See the IDTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDenta Corp is a detection and forensic science company. The firm, through its subsidiary, is engaged in the business of developing products to test for the presence of illegal drugs and explosives for law enforcement agencies, ports and border crossings, shipping hubs, and other organizations. Its product portfolio includes Drug testing kits, Explosive testing kits, Forensic products, Urine drug testing and others. The company currently sells its products to law enforcement organizations in the following countries: Indonesia, Argentina, Poland, France, USA, Spain, India, the United Kingdom, Ghana, Nigeria, Australia, Russia, Israel, Canada, Germany, Italy, and Portugal. The company also sells to retail markets in the United States, Italy, and South Africa.
44GF Score
Get the complete analysis for IDTA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDTA has been successfully added to your 
